MarketInOut Stock Screener Log In | Sign Up

New Ray Medicine International Holding Ltd

HKSE • Healthcare • Pharmaceutical Retailers • Quote as of 10/30/2026
New Ray Medicine International Holding Ltd stock price and volume chart

Company Profile

IndustryPharmaceutical Retailers
SectorHealthcare
ExchangeHKSE
Market Capitalization52.16 mln
Float149 mln
Earnings Date03/31/2027

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-1.65
Likely manipulated

Relative Strength

99 / 100
Top performer

Debt / Equity

0.01
Debt-free

Pre-Tax Margin

-8%
Marginally loss-making

ROE

-3.78
Negative

Business Description

Founded in 2001 and based in Hangzhou, China, New Ray Medicine International Holding Limited distributes and trades a range of pharmaceutical products across the country. Its portfolio covers treatments for conditions such as heart disease, hepatitis, bacterial infections, digestive disorders, and weakened immunity. The company also supports its partners with marketing and promotional services.

Key Fundamentals

EPS-0.09
ROE-3.78
RPS1.08
ROIC-3.40
ROA-3.58
EBITDA, mln-12.08
EV / EBITDA2.16
EV / EBIT1.64
Revenue, mln199

Quote Details

Last 0.335
Change -0.015 (-4.29%)
Open 0.32
Volume 240,000
Turnover 80,400
Average Volume 1,202,386

Financial Ratios

Pre-Tax Profit Margin-8
Current Ratio11.65
Price / Book0.10
Price / Tangible Book0.10
Price / Free Cash Flow3.82
Debt / Equity0.01
Price / Sales0.24

Financial Strength

Altman Z-Score2.8
Piotroski F-Score 5 / 9
Beneish M-Score-1.65
Price to Intrinsic Value11.30

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 28.85% 99 / 100   
1 Month 58.77% 99 / 100   
2 Months 63.41% 97 / 100   
6 Months 64.22% 95 / 100   
1 Year -19.28% 51 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog